Prevest Denpro Limited

Healthcare · Healthcare Equipment & Supplies

BSE: 543363
₹379.95
▼ -5.00 (-1.30%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
67/100
Moderate
Valuation
—/100
Data unavailable
Momentum
65/100
Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹456 Cr
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
1.44%
FII + DII, latest filed period
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-29.0
Free Cash Flow
₹13 Cr
as of March 31, 2026
Industry median ₹-4 Cr (17 companies)
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
24.77%
as of June 30, 2026
Industry median 24.77% (9 companies)
Revenue Growth (YoY)
23.66%
as of June 30, 2026
Industry median 12.25% (11 companies)
Current Ratio
14.91
as of March 31, 2026
Industry median 3.04 (17 companies)
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
1376.24
as of March 31, 2026
Industry median 12.12 (11 companies)
Net Margin
29.74%
as of June 30, 2026
Industry median 5.41% (10 companies)
Operating Margin (EBIT)
39.62%
as of June 30, 2026
Industry median 9.40% (11 companies)
Operating Margin (TTM)
38.88%
as of June 30, 2026
Industry median 13.81% (11 companies)
Return on Assets
13.99%
as of March 31, 2026
Industry median 4.45% (10 companies)
Return on Capital Employed
20.04%
as of March 31, 2026
Industry median 8.85% (11 companies)
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 3 met
  • No Quality score is Strong (70 or more)
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

3 of 3 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

1 of 3 met
  • No 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

0 of 4 met
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-1.3%
Low 378.6000 · High 384.7500
1W return
-1.0%
Low 372.0000 · High 386.9500
1M return
-0.7%
Low 371.0500 · High 438.8000
52W return
-33.0%
Low 371.0500 · High 438.8000
Lifetime High ₹626.8000 (July 4, 2024)
Lifetime Low ₹179.6000 (Sept. 30, 2021)

Full price history and technicals →

EMA & SMA

Bullish0
Bearish6
5D
381.6
10D
382.2
20D
386.5
50D
402.3
100D
410.6
200D
411.7

Delivery and volume

Day avg. delivery
79.2%
Week avg. delivery
81.5%
Month avg. delivery
79.3%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

381.10
Pivot
First resistance383.60
Second resistance387.25
Third resistance389.75
First support377.45
Second support374.95
Third support371.30
Day RSI43.9
Day MFI83.4
Day MACD-7.66
Day MACD signal-9.66

Beta

1M0.53
3M0.19
1Y0.19
3Y1.03

Price change analysis

↓ -0.7%
Over 1 Month
LowHigh
371.05438.80
↓ -33.0%
Over 3 Months
LowHigh
371.05438.80
↓ -33.0%
Over 6 Months
LowHigh
371.05438.80
↓ -33.0%
Over 1 Year
LowHigh
371.05438.80
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹19 Cr
Net profit (June 30, 2026)
₹6 Cr
Basic EPS (June 30, 2026)
₹

Ranks #6 of 13 in Healthcare Equipment & Supplies by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter73.60%
  • FII/FPI0.65%
  • Public24.96%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 73.60% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings were unchanged at 0.65% in Jun 2026 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
23 Mar 2026 PANKAJ PRASOON AND (HUF) Bulk Buy 144,000 369.2200 BSE
23 Mar 2026 PUSHPA KUMARI PANKAJ PRASOON Bulk Sell 150,600 366.4600 BSE
23 Mar 2026 PANKAJ PRASOON Bulk Buy 156,600 368.5100 BSE
9 Feb 2022 RAMLAL KANWARLAL JAIN Bulk Sell 64,000 345.1600 BSE
31 Jan 2022 VINOD H BIYANI Bulk Sell 12,800 401.2600 BSE
31 Jan 2022 VINOD H BIYANI Bulk Buy 128,000 390.5000 BSE
31 Jan 2022 NEXT ORBIT VENTURES FUND Bulk Sell 147,200 391.1700 BSE
3 Jan 2022 RAMLAL KANWARLAL JAIN Bulk Buy 72,000 454.9100 BSE
31 Dec 2021 NEXT ORBIT VENTURES FUND Bulk Buy 3,200 433.7500 BSE
31 Dec 2021 NEXT ORBIT VENTURES FUND Bulk Sell 78,400 433.7500 BSE

All bulk and block deals →

Ex-dateSubjectPer share (₹)Record date
— Final Dividend - Rs. - 1.0000 — —

Corporate Announcements

All 2 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
28 Sep 2026 Insider Trading / SAST Prevest Denpro Ltd - 543363 - Closure of Trading Window
19 Sep 2026 AGM/EGM Prevest Denpro Ltd - 543363 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Strong net profit margin (29.7%)
  • Comfortable interest coverage (1376.2x)
  • Strong revenue growth YoY (23.7%)

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

  • Down 33.0% over the past year

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Prevest Denpro Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.